Oncoclew CO.,LTD is best partner for cancer research and developing cancer therapeutics.
Our core technologies are as follows.
1. TDEA (tumoroid based drug efficacy testing assay) – In tumoroid biobank, the test group can be selected based on the types of cancer origins, genotypes, and phenotypes desired by sponsor, and drug efficacy assay is carried out by expert research team.
2. TDRA (tumoroid drug response assay) – a next-generation anti-cancer drug response assay based on patient-derived tumoroids.
3. TBDD (tumoroid & big-data based drug development) – Drug efficacy assay and hit finding, biomarker identification, finding new targets and drug repositionsing, patient segmentation expansion.